NCT02654652 Impact of Symbiotic Administration on Intestinal Function of Head and Neck Patients Surgically Treated Status COMPLETED Phase NA
NCT02646748 Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02641093 Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02609503 Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin Status COMPLETED Phase PHASE2
NCT02597738 A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine Status ACTIVE_NOT_RECRUITING Phase NA
NCT02594696 Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness Status COMPLETED Phase NA
NCT02589938 Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer Status COMPLETED Phase NA
NCT02577237 Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer Status COMPLETED Phase NA
NCT02576665 A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) Status TERMINATED Phase PHASE1
NCT02573493 Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) Status COMPLETED Phase PHASE2
NCT02572869 Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps Status COMPLETED Phase N/A
NCT02572661 Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT) Status COMPLETED Phase NA
NCT02571673 Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR) Status COMPLETED Phase N/A
NCT02563470 Bleeding, Cardio- and Cerebrovascular Complications in Head and Neck Surgery Status COMPLETED Phase N/A
NCT02554968 Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer Status COMPLETED Phase N/A
NCT02544880 PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC Status COMPLETED Phase PHASE1